share_log

12 Health Care Stocks Moving In Monday's Pre-Market Session

Benzinga ·  May 13 20:06

Gainers

  • Tevogen Bio Holdings (NASDAQ:TVGN) stock rose 55.4% to $1.53 during Monday's pre-market session. The market value of their outstanding shares is at $251.8 million.
  • MiNK Therapeutics (NASDAQ:INKT) stock increased by 31.09% to $1.18. The company's market cap stands at $40.9 million.
  • Dynatronics (NASDAQ:DYNT) stock increased by 21.69% to $0.57. The company's market cap stands at $2.8 million. As per the press release, Q3 earnings came out 2 days ago.
  • Tarsus Pharmaceuticals (NASDAQ:TARS) shares moved upwards by 18.08% to $43.69. The market value of their outstanding shares is at $1.6 billion. As per the news, the Q1 earnings report came out 3 days ago.
  • CareCloud (NASDAQ:CCLD) shares increased by 15.07% to $1.45. The company's market cap stands at $23.3 million.
  • Fulcrum Therapeutics (NASDAQ:FULC) shares rose 13.78% to $8.5. The market value of their outstanding shares is at $528.3 million. The company's, Q1 earnings came out today.

Losers

  • Applied DNA Sciences (NASDAQ:APDN) stock declined by 13.1% to $3.0 during Monday's pre-market session. The market value of their outstanding shares is at $2.5 million. As per the news, the Q2 earnings report came out yesterday.
  • Portage Biotech (NASDAQ:PRTG) shares declined by 12.81% to $0.22. The market value of their outstanding shares is at $4.3 million.
  • TransCode Therapeutics (NASDAQ:RNAZ) stock fell 12.06% to $1.24. The market value of their outstanding shares is at $7.5 million.
  • Fortrea Holdings (NASDAQ:FTRE) stock fell 9.09% to $30.03. The company's market cap stands at $2.6 billion. The company's, Q1 earnings came out today.
  • NovaBay Pharmaceuticals (AMEX:NBY) shares declined by 9.08% to $0.07. The company's market cap stands at $2.6 million. The company's, Q1 earnings came out 2 days ago.
  • 60 Degrees (NASDAQ:SXTP) stock decreased by 8.89% to $0.2. The market value of their outstanding shares is at $2.3 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment